Content
S Trulieve Q1 Financials Report Record Revenue And EBITDA; Major Reduction In Net Loss
Article By:
Lorimer Wilson
Read
Monday, May 16, 2022 2:29 AM EDT
Truilive's stock price was up 9.6% as of the end of trading this past Friday based on the impressive Q1 financial results but it remains -38.6% YTD and -72.0% from its high in 2021.
In this article: TCNNF
S 2 Of The 5 Cannabis Categories Advance Slightly
Article By:
Lorimer Wilson
Read
Saturday, May 14, 2022 9:26 PM EDT
During the second week of May, two of the 5 categories we index showed some improvement; here, the numbers for all the stocks in all 5 categories for last week, YTD and from the 2021 peak.
S Aurora Cannabis Stock Advances Despite Poor Q3 Financial Results
Article By:
Lorimer Wilson
Read
Friday, May 13, 2022 5:42 PM EDT
Despite unimpressive Q3 financial results reported yesterday, Aurora's stock price has increased but it remains down 49.4% YTD and still remains down 85.5% from its 2021 high.
In this article: ACB
S American Multi-State Cannabis Operators Imploding - Down 46% YTD; Down 75% From 2021 High
Article By:
Lorimer Wilson
Read
Friday, May 13, 2022 1:19 PM EDT
The general market weakness and the continuing disappointment in the delay in the introduction of the Senate's cannabis bill have the largest American multi-state operators (MSOs) imploding.
S Cronos Group Has Bounced Off 52-Week Low With Report Of Much Improved Q1 Financial Results
Article By:
Lorimer Wilson
Read
Tuesday, May 10, 2022 1:28 PM EDT
Cronos Group Inc. announced its Q1 2022 business results for the period ending March 31st, 2022.
In this article: CRON
S Curaleaf Q1 Financial Metrics DOWN Across The Board: Stock Declined 5.8% Today
Article By:
Lorimer Wilson
Read
Tuesday, May 10, 2022 4:34 AM EDT
While Curaleaf's stock price was unchanged during the first week of May in expectation of a favorable Q1 financial report that did not materialize going DOWN 5.8% today.
In this article: CURLF
S Psychedelic Stocks Continue To Decline In May
Article By:
Lorimer Wilson
Read
Sunday, May 8, 2022 12:01 AM EDT
The 10 companies in our Psychedelic Compounds-Based Drug Stocks Index are clinical-stage startups still in the product research and development of novel compounds with no products and no revenue.
S Update: 13 Largest American Marijuana Stocks Plunged 27.5% In April
Article By:
Lorimer Wilson
Read
Monday, May 2, 2022 2:25 PM EDT
U.S. federal legalization related to cannabis companies still faces hurdles but state-level momentum is projected to continue this year. Below is the performance in April and YTD of the 13 largest American Multi-State Operators (MSOs).
In this article: TCNNF, AAWH, CRLBF, GTBIF, TRSSF, PLNHF, CURLF, AYRWF, CCHWF, JUSHF, VRNOF, GDNSF, ACRDF, ACRHF
S European Cannabis Q1 2022 Quarterly Update
Article By:
Michael Sassano
Read
Thursday, April 28, 2022 9:07 PM EDT
Just like the United States’ state-by-state movement, Europe is moving country-by-country toward providing access to cannabis.